Internal Medicine, Medical Oncology · Lebanon, NH
NPI
1871680942
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1 Medical Center Drive
Lebanon, NH, 03756
Phone (603) 650-5747
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
267 services
Medicare patients, 2024
110
Average age 74
Drug cost, 2024
$308K
325 prescriptions
Company payments, 2025
$152
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Linda T Vahdat was code 99215 (office e&m - established), 151 times for 70 patients. In total Linda T Vahdat billed 267 services in 10 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 151 | 70 | $106.13 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 30 | 24 | $12.77 | $383 |
| 99215 Office E&M - Established | Office | 29 | 17 | $106.40 | $3,085 |
| 99205 Office E&M - New | Facility | 28 | 28 | $139.58 | $3,908 |
By year: 2022 $23K for 193 services; 2023 $31K for 283 services; 2024 $26K for 267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Linda T Vahdat prescribed most often to Medicare patients was Anastrozole, with 128 prescriptions and refills. In total Linda T Vahdat wrote 325 Medicare prescriptions that cost $308K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 128 | 364 | 55 | $3,260 |
| Letrozole Generic | 49 | 135 | 23 | $1,393 |
| Tamoxifen Citrate Generic | 43 | 129 | 17 | $1,418 |
| Alendronate Sodium Generic | 21 | 57 | 11 | $158 |
| Arimidex Anastrozole | 18 | 22 | Under 11 | $36K |
| Ibrance Palbociclib | 17 | 17 | Under 11 | $240K |
Brand drugs: 38 claims; generic drugs: 287 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Linda T Vahdat $152 ($152 in general payments such as food, travel and fees) from 3 companies. The largest payer was Stemline Therapeutics Inc. with $142.
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $142 |
| R-Pharm US LLC | 1 | $10 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.